DocGo (NASDAQ:DCGO – Get Free Report) had its price target lowered by investment analysts at Stifel Nicolaus from $11.00 to $8.00 in a report issued on Wednesday, Benzinga reports. The firm currently has a “buy” rating on the stock. Stifel Nicolaus’ price objective indicates a potential upside of 138.45% from the company’s current price. Several […]
DocGo (NASDAQ:DCGO – Get Free Report) had its price objective cut by stock analysts at BTIG Research from $13.00 to $11.00 in a note issued to investors on Wednesday, Benzinga reports. The firm currently has a “buy” rating on the stock. BTIG Research’s price target suggests a potential upside of 227.87% from the company’s previous […]
P.A.W. Capital Corp lifted its stake in DocGo Inc. (NASDAQ:DCGO – Free Report) by 50.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 900,000 shares of the company’s stock after buying an additional 300,000 shares during the period. DocGo comprises 12.2% of […]
DocGo Inc. (NASDAQ:DCGO – Free Report) – Analysts at Northland Capmk dropped their FY2024 earnings per share estimates for shares of DocGo in a research note issued to investors on Tuesday, April 9th. Northland Capmk analyst M. Latimore now forecasts that the company will post earnings per share of $0.27 for the year, down from […]
DocGo (NASDAQ:DCGO – Get Free Report) had its target price decreased by equities research analysts at Canaccord Genuity Group from $10.00 to $9.00 in a research note issued on Thursday, Benzinga reports. The firm presently has a “buy” rating on the stock. Canaccord Genuity Group’s price objective would indicate a potential upside of 168.66% from […]